$343.64
+2.49
(+0.73%)▲
Cigna Corp is a global health service company that provides medical, dental, and disability insurance plans.
0.28%
Downside
Day's Volatility :1.09%
Upside
0.81%
26.71%
Downside
52 Weeks Volatility :30.85%
Upside
5.65%
Period | The Cigna Corp | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | -3.76% | 6.5% | 5.9% |
6 Months | 14.55% | 7.1% | 10.4% |
1 Year | 17.36% | 9.8% | 18.2% |
3 Years | 49.34% | 14.2% | 22.1% |
Market Capitalization | 97.2B |
Book Value | $144.9 |
Dividend Share | 5.09 |
Dividend Yield | 1.64% |
Earnings Per Share (EPS) | 12.18 |
PE Ratio | 28.1 |
PEG Ratio | 0.89 |
Wall Street Target Price | 393.25 |
Profit Margin | 1.77% |
Operating Margin TTM | 0.81% |
Return On Assets TTM | 3.08% |
Return On Equity TTM | 8.97% |
Revenue TTM | 204.1B |
Revenue Per Share TTM | 700.13 |
Quarterly Revenue Growth YOY | 19.3% |
Gross Profit TTM | 23.0B |
EBITDA | 9.2B |
Diluted Eps TTM | 12.18 |
Quarterly Earnings Growth YOY | -0.1 |
EPS Estimate Current Year | 28.5 |
EPS Estimate Next Year | 32.01 |
EPS Estimate Current Quarter | 6.22 |
EPS Estimate Next Quarter | 6.93 |
What analysts predicted
Upside of 14.44%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 48.6B | ↑ 15.52% |
Net Income | 2.6B | ↑ 17.88% |
Net Profit Margin | 5.43% | ↑ 0.11% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 153.7B | ↑ 216.55% |
Net Income | 5.1B | ↑ 93.55% |
Net Profit Margin | 3.32% | ↓ 2.11% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 160.6B | ↑ 4.45% |
Net Income | 8.5B | ↑ 65.71% |
Net Profit Margin | 5.27% | ↑ 1.95% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 174.3B | ↑ 8.53% |
Net Income | 5.4B | ↓ 36.51% |
Net Profit Margin | 3.08% | ↓ 2.19% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 180.6B | ↑ 3.66% |
Net Income | 6.7B | ↑ 24.84% |
Net Profit Margin | 3.71% | ↑ 0.63% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 195.2B | ↑ 8.05% |
Net Income | 5.2B | ↓ 22.97% |
Net Profit Margin | 2.65% | ↓ 1.06% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 45.8B | ↑ 1.22% |
Net Income | 1.2B | ↓ 57.6% |
Net Profit Margin | 2.56% | ↓ 3.54% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 46.5B | ↑ 1.55% |
Net Income | 1.3B | ↑ 8.38% |
Net Profit Margin | 2.73% | ↑ 0.17% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 48.6B | ↑ 4.64% |
Net Income | 1.5B | ↑ 15.23% |
Net Profit Margin | 3.0% | ↑ 0.27% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 49.0B | ↑ 0.89% |
Net Income | 41.0M | ↓ 97.19% |
Net Profit Margin | 0.08% | ↓ 2.92% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 51.1B | ↑ 4.14% |
Net Income | 1.0B | ↑ 2409.76% |
Net Profit Margin | 2.01% | ↑ 1.93% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 55.4B | ↑ 8.49% |
Net Income | -277.0M | ↓ 126.92% |
Net Profit Margin | -0.5% | ↓ 2.51% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 153.2B | ↑ 148.13% |
Total Liabilities | 112.2B | ↑ 133.81% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 155.8B | ↑ 1.66% |
Total Liabilities | 110.4B | ↓ 1.57% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 155.5B | ↓ 0.21% |
Total Liabilities | 105.1B | ↓ 4.83% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 154.9B | ↓ 0.36% |
Total Liabilities | 107.7B | ↑ 2.51% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 143.9B | ↓ 7.07% |
Total Liabilities | 99.0B | ↓ 8.1% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 147.9B | ↑ 2.77% |
Total Liabilities | 101.6B | ↑ 2.62% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 143.9B | ↓ 0.19% |
Total Liabilities | 99.0B | ↓ 0.1% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 148.0B | ↑ 2.81% |
Total Liabilities | 103.4B | ↑ 4.44% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 150.1B | ↑ 1.4% |
Total Liabilities | 104.5B | ↑ 1.11% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 149.6B | ↓ 0.27% |
Total Liabilities | 103.9B | ↓ 0.62% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 147.9B | ↓ 1.15% |
Total Liabilities | 101.6B | ↓ 2.22% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 148.4B | ↑ 0.35% |
Total Liabilities | 107.1B | ↑ 5.44% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 3.8B | ↓ 7.73% |
Investing Cash Flow | -26.4B | ↑ 1448.91% |
Financing Cash Flow | 23.5B | ↓ 987.02% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 9.5B | ↑ 151.59% |
Investing Cash Flow | -734.0M | ↓ 97.22% |
Financing Cash Flow | -7.2B | ↓ 130.56% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 10.4B | ↑ 9.12% |
Investing Cash Flow | 3.0B | ↓ 505.45% |
Financing Cash Flow | -8.5B | ↑ 18.73% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 7.2B | ↓ 30.52% |
Investing Cash Flow | -3.6B | ↓ 221.34% |
Financing Cash Flow | -8.2B | ↓ 3.76% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 8.7B | ↑ 20.37% |
Investing Cash Flow | 3.1B | ↓ 185.79% |
Financing Cash Flow | -11.2B | ↑ 36.87% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.1B | ↓ 36.06% |
Investing Cash Flow | 3.1B | ↓ 30.32% |
Financing Cash Flow | -2.6B | ↓ 52.22% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 5.0B | ↑ 139.54% |
Investing Cash Flow | -3.0B | ↓ 196.29% |
Financing Cash Flow | -37.0M | ↓ 98.6% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.5B | ↓ 50.44% |
Investing Cash Flow | -414.0M | ↓ 86.12% |
Financing Cash Flow | -435.0M | ↑ 1075.68% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.8B | ↑ 13.4% |
Investing Cash Flow | -4.7B | ↑ 1043.48% |
Financing Cash Flow | -2.6B | ↑ 491.26% |
Sell
Neutral
Buy
The Cigna Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() The Cigna Corp | 1.06% | 14.55% | 17.36% | 49.34% | 103.92% |
![]() Unitedhealth Group Incorporated | 15.63% | 11.22% | 10.17% | 35.34% | 121.27% |
![]() Cvs Health Corporation | -3.27% | -19.66% | -21.9% | -29.23% | 5.6% |
![]() Humana Inc. | 7.01% | 6.97% | -13.79% | -17.31% | 39.56% |
![]() Elevance Health, Inc | -3.8% | 6.25% | 9.46% | 35.81% | 71.35% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() The Cigna Corp | 28.1 | 28.1 | 0.89 | 28.5 | 0.09 | 0.03 | 0.02 | 144.9 |
![]() Unitedhealth Group Incorporated | 37.05 | 37.05 | 1.24 | 25.54 | 0.16 | 0.07 | 0.02 | 102.02 |
![]() Cvs Health Corporation | 10.27 | 10.27 | 1.0 | 6.43 | 0.1 | 0.03 | 0.05 | 59.08 |
![]() Humana Inc. | 23.82 | 23.82 | 1.64 | 16.34 | 0.12 | 0.05 | 0.01 | 133.86 |
![]() Elevance Health, Inc | 18.22 | 18.22 | 1.14 | 37.26 | 0.17 | 0.06 | 0.01 | 181.94 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() The Cigna Corp | Buy | $97.2B | 103.92% | 28.1 | 1.77% |
![]() Unitedhealth Group Incorporated | Buy | $515.2B | 121.27% | 37.05 | 3.66% |
![]() Cvs Health Corporation | Buy | $73.5B | 5.6% | 10.27 | 2.04% |
![]() Humana Inc. | Buy | $46.5B | 39.56% | 23.82 | 1.82% |
![]() Elevance Health, Inc | Buy | $120.8B | 71.35% | 18.22 | 3.9% |
Insights on The Cigna Corp
Revenue is up for the last 7 quarters, 45.19B → 55.41B (in $), with an average increase of 3.3% per quarter
Netprofit is down for the last 2 quarters, 1.02B → -277.0M (in $), with an average decrease of 126.9% per quarter
Vanguard Group Inc
BlackRock Inc
FMR Inc
T. Rowe Price Associates, Inc.
State Street Corporation
Dodge & Cox
In the quarter ending March,2024. The Cigna Corp has declared dividend of $1.4
Read MoreThe Cigna Group is a global health services company. The Companys portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare.
Organization | The Cigna Corp |
Employees | 70325 |
CEO | Mr. David Michael Cordani |
Industry | Health Services |